Drug Trials Snapshots: EXDENSUR - EXDENSUR (depemokimab)

https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-exdensur EXDENSUR is a medication that is approved for the add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in adult and pediatric patients aged 12 years and older.